Drug Search Results
More Filters [+]

PACAP-38

Alternative Names: pacap-38, pacap, pacap38
Latest Update: 2024-06-05
Latest Update Note: News Article

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Large Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Amgen
Company Location: THOUSAND OAKS CA 91320
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for PACAP-38

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Migraine Disorders

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

H-21048416

N/A

Unknown status

Post-Traumatic Headache

2023-12-31

H22038923

N/A

Completed

Migraine Disorders

2023-08-04

H19065735

N/A

Completed

Headache|Migraine Disorders

2021-03-19

H-17011569

N/A

Unknown status

Cluster Headache

2020-01-01

Recent News Events